SEETHARAM KANDARPA
Homepage
About Me
Contact Me
Our Team
Knowledge Bank
Key Info
Useful Info
Videos
ASQ Certification
ASQ-CQA
ASQ-CPGP
News
Blog
Homepage
>
Tag list
Tag: ema
GMP-Audits of manufacturers of active substances: Minimum Requirements on Audit Reports and Qualification of Auditors
https://seetharamkandarpa.webnode.in/news/gmp-audits-of-manufacturers-of-active-substances-minimum-requirements-on-audit-reports-and-qualification-of-auditors/
Guideline on the European Drug Master File Procedure updated
https://seetharamkandarpa.webnode.in/news/guideline-on-the-european-drug-master-file-procedure-updated/
Final EMA Variations Guideline on Procedures Issues and Classification of Variations published
https://seetharamkandarpa.webnode.in/news/final-ema-variations-guideline-on-procedures-issues-and-classification-of-variations-published/
EU-GMP: New Annex 16 released
https://seetharamkandarpa.webnode.in/news/eu-gmp-new-annex-16-released/
Written Confirmation: A Questions & Answer Document of the Danish Authority provides further Clarifications
https://seetharamkandarpa.webnode.in/news/written-confirmation-a-questions-answer-document-of-the-danish-authority-provides-further-clarifications/
New EMA Inspection Requirements on Good Distribution Practices (GDP)
https://seetharamkandarpa.webnode.in/news/new-ema-inspection-requirements-on-good-distribution-practices-gdp-/
Variations: Important Changes in the New Application Form
https://seetharamkandarpa.webnode.in/news/variations-important-changes-in-the-new-application-form/
New EMA Guideline on Starting Materials from Biological Medicinal Products
https://seetharamkandarpa.webnode.in/news/new-ema-guideline-on-starting-materials-from-biological-medicinal-products/
Updated Procedure for the Renewal and Revision of CEPs!
https://seetharamkandarpa.webnode.in/news/updated-procedure-for-the-renewal-and-revision-of-ceps-/
EMA Guideline on the use of bovine serum in the manufacture of human biological medicinal products
https://seetharamkandarpa.webnode.in/news/ema-guideline-on-the-use-of-bovine-serum-in-the-manufacture-of-human-biological-medicinal-products/
Frequently asked GMP question: How should active substance auditors be qualified?
https://seetharamkandarpa.webnode.in/news/frequently-asked-gmp-question-how-should-active-substance-auditors-be-qualified-/
EMA publishes Guideline on Pharmaceutical Development of Medicines for Paediatric Use
https://seetharamkandarpa.webnode.in/news/ema-publishes-guideline-on-pharmaceutical-development-of-medicines-for-paediatric-use/
Quality by Design: Lessons learnt from EMA/FDA Pilot Program
https://seetharamkandarpa.webnode.in/news/quality-by-design-lessons-learnt-from-ema-fda-pilot-program/
EMA published Concept Paper on the Revision of the Finished Dosage Form Guideline
https://seetharamkandarpa.webnode.in/news/ema-published-concept-paper-on-the-revision-of-the-finished-dosage-form-guideline/
EMA Guideline on Quality of biological active Substances produced by transgene Expression in Animals
https://seetharamkandarpa.webnode.in/news/ema-guideline-on-quality-of-biological-active-substances-produced-by-transgene-expression-in-animals/
EMA publishes revised dossier-submission requirements for active-substance master files
https://seetharamkandarpa.webnode.in/news/ema-publishes-revised-dossier-submission-requirements-for-active-substance-master-files/
European Medicines Agency and US Food and Drug Administration release further guidance on quality-by-design approach
https://seetharamkandarpa.webnode.in/news/european-medicines-agency-and-us-food-and-drug-administration-release-further-guidance-on-quality-by-design-approach/
EMA now also issues GMP and GDP Non-Compliance Information
https://seetharamkandarpa.webnode.in/news/ema-now-also-issues-gmp-and-gdp-non-compliance-information/
How to submit an Active Substance Master File?
https://seetharamkandarpa.webnode.in/news/how-to-submit-an-active-substance-master-file-/
Update: Electronic Submission of Marketing Authorisation Dossiers
https://seetharamkandarpa.webnode.in/news/update-electronic-submission-of-marketing-authorisation-dossiers/
GCP and Bioequivalence Studies: new FDA/EMA Initiative
https://seetharamkandarpa.webnode.in/news/gcp-and-bioequivalence-studies-new-fda-ema-initiative/
New EMA Guidance Qualification of novel Methodologies for Drug Development
https://seetharamkandarpa.webnode.in/news/new-ema-guidance-qualification-of-novel-methodologies-for-drug-development/
My new Mobile Application "SRK GCP World"
https://seetharamkandarpa.webnode.in/news/my-new-mobile-application-srk-gcp-world/
New Process Validation Guideline by EMA
https://seetharamkandarpa.webnode.in/news/new-process-validation-guideline-by-ema/
New EMA Guideline on Stability Testing for Applications for Variations
https://seetharamkandarpa.webnode.in/news/new-ema-guideline-on-stability-testing-for-applications-for-variations/
EMA: Changes to Handling of Variations
https://seetharamkandarpa.webnode.in/news/ema-changes-to-handling-of-variations/
Draft Guideline on Validation of biotechnology-derived Products by EMA
https://seetharamkandarpa.webnode.in/news/draft-guideline-on-validation-of-biotechnology-derived-products-by-ema/
Qualification of a Responsible Person for GDP- UK Gold Standard
https://seetharamkandarpa.webnode.in/news/qualification-of-a-responsible-person-for-gdp-uk-gold-standard/
EMA Official Details Obstacles to Reaching Mutual Reliance on GMP Inspections
https://seetharamkandarpa.webnode.in/news/ema-official-details-obstacles-to-reaching-mutual-reliance-on-gmp-inspections/
HMPC Q&A Documents on Herbal Medicinal Products
https://seetharamkandarpa.webnode.in/news/hmpc-q-a-documents-on-herbal-medicinal-products/
Final QP Declaration Template by EMA
https://seetharamkandarpa.webnode.in/news/final-qp-declaration-template-by-ema/
New Procedure for co-ordinating GCP-Inspections by CHMP
https://seetharamkandarpa.webnode.in/news/new-procedure-for-co-ordinating-gcp-inspections-by-chmp/
GMP Non-compliance reports (AGEPHA, Austria) Published by EMA
https://seetharamkandarpa.webnode.in/news/gmp-non-compliance-reports-agepha-austria-published-by-ema/
GMP Non-compliance reports (North China Pharmaceutical Group Semisyntech Co., Ltd, China) Published by EMA
https://seetharamkandarpa.webnode.in/news/gmp-non-compliance-reports-north-china-pharmaceutical-group-semisyntech-co-ltd-china-published-by-ema-/
Update of Guideline on the packaging information of medicinal products for human use authorised by the Union (July 2015) [EudraLex - Volume 2]
https://seetharamkandarpa.webnode.in/news/update-of-guideline-on-the-packaging-information-of-medicinal-products-for-human-use-authorised-by-the-union-july-2015-eudralex-volume-2/
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
https://seetharamkandarpa.webnode.in/news/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-centralised-procedure/
Reflection paper on the chemical structure and properties criteria to be considered for the evaluation of new active substance (NAS) status of chemical substances
https://seetharamkandarpa.webnode.in/news/reflection-paper-on-the-chemical-structure-and-properties-criteria-to-be-considered-for-the-evaluation-of-new-active-substance-nas-status-of-chemical-substances/
EMA revises Guide on Pharmaceutical Water
https://seetharamkandarpa.webnode.in/news/ema-revises-guide-on-pharmaceutical-water/
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 April 2017
https://seetharamkandarpa.webnode.in/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-18-21-april-2017/
Regulatory information - adjusted fees for applications to EMA from 1 April 2017
https://seetharamkandarpa.webnode.in/news/regulatory-information-adjusted-fees-for-applications-to-ema-from-1-april-2017/
EMA Q&A on GCP
https://seetharamkandarpa.webnode.in/news/ema-q-a-on-gcp/
Brexit preparedness: EMA to further temporarily scale back and suspend activities
https://seetharamkandarpa.webnode.in/news/brexit-preparedness-ema-to-further-temporarily-scale-back-and-suspend-activities/
Targeted stakeholder consultation on the draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products
https://seetharamkandarpa.webnode.in/news/targeted-stakeholder-consultation-on-the-draft-guidelines-on-good-clinical-practice-for-advanced-therapy-medicinal-products/
Search site
About Me
SEETHARAM KANDARPA
Seetharam Kandarpa Receives ASQ-Certified Manager of Quality/Organizational Excellence
Web Series 2 of ASQ CQA Mentoring Class: Auditing Fundamentals on 30 July 2017
Overview of ASQ Certified Pharmaceutical GMP Professional (CPGP)
Web Series Session 1: Overview of ASQ Certified Quality Auditor conducted on 21 May 2017
Register to Join Mentoring Class for ASQ-CQA
Mentoring Class for ASQ-CQA
G.ONE (GMP-ONE)- One Spot for all GMP Links required in our JEEVAN
Seetharam Kandarpa Receives ASQ Quality Auditor
Seetharam Kandarpa Receives ASQ-Certified Pharmaceutical GMP Professional
ISO 9001: 2008 Quality Management Systems – Requirements
My new Mobile Application "SRK GCP World"
MACO Calculation Sheet in Cleaning Validation
My new Mobile Application "SRK GMP Videos"
"SRK CLEANING VALIDATION"- My new mobile application
"SRK GMP OCEAN"- My Mobile Application Works for Android & HTML5
"SRK GMP FAQ"- My new Mobile Application
DO YOU FEEL TO COMMENT ON THIS WEBSITE? PLEASE GO TO GUESTBOOK...
DO YOU WANT TO PARTICIPATE IN KNOWLEDGE DISCUSSION FORUM?
To view updated/ new content, click tag "WHAT IS NEW"....
DO Dd
Homepage
Site map
RSS
Print
This website was built with Webnode
You can also have an impressive website for free!
Try it out